Transphorm, Inc. (TGAN)
Jun 20, 2024 - TGAN was delisted (reason: acquired by Renesas)
5.10
+0.34 (7.14%)
Inactive · Last trade price on Jun 20, 2024

Transphorm Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year Ending
TTM Mar '23 Mar '22 Dec '20 Dec '19 Dec '18
Revenue
18.7616.5124.0511.3711.931.36
Revenue Growth (YoY)
2.79%-31.35%111.50%-4.72%778.79%-
Cost of Revenue
15.2417.4612.536.686.494.6
Gross Profit
3.51-0.9511.524.695.44-3.24
Selling, General & Admin
22.3118.9214.7612.59.229.3
Research & Development
11.748.916.665.588.159.35
Operating Expenses
34.0527.8321.4218.0917.3618.65
Operating Income
-30.54-28.78-9.9-13.4-11.92-21.9
Interest Expense / Income
0.190.730.790.760.760.71
Other Expense / Income
2.641.09-0.453.752.613.19
Pretax Income
-33.37-30.6-10.24-17.91-15.28-25.8
Net Income
-33.37-30.6-10.24-17.91-15.28-25.8
Preferred Dividends
8.3300000
Shares Outstanding (Basic)
62564632284
Shares Outstanding (Diluted)
62564632284
Shares Change
9.60%22.08%45.11%12.74%567.21%-
EPS (Basic)
-0.70-0.54-0.22-0.56-0.54-6.11
EPS (Diluted)
-0.70-0.54-0.22-0.56-0.54-6.11
Free Cash Flow
-24.16-33.33-20.33-14.17-12.49-18.02
Free Cash Flow Per Share
-0.39-0.59-0.44-0.45-0.44-4.27
Gross Margin
18.73%-5.75%47.90%41.24%45.60%-238.81%
Operating Margin
-162.84%-174.29%-41.15%-117.82%-99.87%-1612.30%
Profit Margin
-222.34%-185.32%-42.56%-157.50%-128.06%-1899.71%
Free Cash Flow Margin
-128.84%-201.89%-84.54%-124.64%-104.68%-1326.73%
EBITDA
-31.48-28.33-8.6-16.31-13.31-23.71
EBITDA Margin
-167.85%-171.61%-35.76%-143.47%-111.52%-1746.24%
Depreciation & Amortization
1.71.530.840.841.221.37
EBIT
-33.18-29.87-9.44-17.15-14.53-25.09
EBIT Margin
-176.91%-180.90%-39.26%-150.81%-121.71%-1847.42%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).